The preclinical data presented at ACR Convergence underscore the exceptional potential of our targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4, which are ...
WASHINGTON, Nov. 16, 2024 /PRNewswire/ -- Physicians are learning how to better support the needs of people with rheumatoid arthritis (RA) from online search trends, according to a new study from ...
Other relevant products include Imbruvica, used for certain types of blood cancer; Skyrizi, to combat autoimmune diseases, primarily psoriasis; Botox, for cosmetic and therapeutic uses; Vraylar, for ...
The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.